Literature DB >> 12149189

Dangerous liaisons: the role of "danger" signals in the immune response to gene therapy.

Brian D Brown1, David Lillicrap.   

Abstract

Recent studies in gene transfer suggest that the innate immune system plays a significant role in impeding gene therapy. In this review, we examine factors that might influence the recruitment and activation of the innate system in the context of gene therapy. We have adopted a novel model of immunology that contends that the immune system distinguishes not between self and nonself, but between what is dangerous and what is not dangerous. In taking this perspective, we provide an alternative and complementary insight into some of the failures and successes of current gene therapy protocols.

Mesh:

Year:  2002        PMID: 12149189     DOI: 10.1182/blood-2001-11-0067

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Loss of transgene following ex vivo gene transfer is associated with a dominant Th2 response: implications for cutaneous gene therapy.

Authors:  Zhenmei Lu; Soosan Ghazizadeh
Journal:  Mol Ther       Date:  2007-03-13       Impact factor: 11.454

Review 2.  Endothelial progenitor cell-based therapy for hemophilia A.

Authors:  Hideto Matsui
Journal:  Int J Hematol       Date:  2012-02       Impact factor: 2.490

Review 3.  Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications.

Authors:  Brian D Brown; Luigi Naldini
Journal:  Nat Rev Genet       Date:  2009-08       Impact factor: 53.242

4.  In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance.

Authors:  Andrea Annoni; Brian D Brown; Alessio Cantore; Lucia Sergi Sergi; Luigi Naldini; Maria-Grazia Roncarolo
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

Review 5.  Tolerance induction by viral in vivo gene transfer.

Authors:  Eric Dobrzynski; Roland W Herzog
Journal:  Clin Med Res       Date:  2005-11

Review 6.  Unique strategies for therapeutic gene transfer in haemophilia A and haemophilia BWFH State-of-the-Art Session on Therapeutic Gene Transfer Buenos Aires, Argentina.

Authors:  R R Montgomery; P E Monahan; M C Ozelo
Journal:  Haemophilia       Date:  2010-07       Impact factor: 4.287

7.  Induction of immune tolerance to FIX by intramuscular AAV gene transfer is independent of the activation status of dendritic cells.

Authors:  Arpita S Bharadwaj; Meagan Kelly; Dongsoo Kim; Hengjun Chao
Journal:  Blood       Date:  2009-11-17       Impact factor: 22.113

8.  Separating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in rats.

Authors:  David M Markusic; Dirk R de Waart; Jurgen Seppen
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

9.  Sustained viral gene delivery through core-shell fibers.

Authors:  I-Chien Liao; Sulin Chen; Jason B Liu; Kam W Leong
Journal:  J Control Release       Date:  2009-06-17       Impact factor: 9.776

10.  Transgene-specific host responses in cutaneous gene therapy: the role of cells expressing the transgene.

Authors:  Z Zhang; C Kuscu; S Ghazizadeh
Journal:  Gene Ther       Date:  2009-05-14       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.